Cerebral palsy is diagnosed through a combination of observing a child’s movement patterns, performing standardized neurological exams, and brain imaging. There is no single blood test or lab marker that confirms it. Traditionally, most children received a diagnosis between 12 and 24 months of age, but newer clinical tools now make it possible to identify cerebral palsy in infants as young as a few months old.
Early Warning Signs Parents Notice First
The earliest and most common sign of cerebral palsy is a delay in reaching motor milestones like rolling over, sitting, standing, or walking. But even before those milestones are expected, parents and pediatricians can spot subtler clues depending on the child’s age.
In babies younger than 6 months, red flags include feeling unusually stiff or unusually floppy when picked up. A baby’s head may lag behind their body when lifted from lying on their back. Some infants seem to constantly push away when cradled, arching their back and neck. When picked up, their legs may stiffen and cross in a scissoring motion.
After 6 months, the signs shift. A baby who doesn’t roll over in either direction, can’t bring both hands together, has trouble getting their hands to their mouth, or consistently reaches with only one hand while keeping the other in a fist is showing patterns that warrant evaluation. By 10 months, lopsided crawling (pushing off with one side while dragging the other) or scooting on the buttocks instead of crawling on all fours are additional warning signs. None of these signs alone confirms cerebral palsy, but they tell a doctor that further assessment is needed.
Standardized Clinical Exams
Once a concern is raised, doctors use specific neurological exams designed for infants. Two tools are central to early detection, and which one is used depends largely on the baby’s age.
For infants younger than about 5 months (adjusted for prematurity), a method called the General Movements Assessment evaluates the quality of a baby’s spontaneous movements. Clinicians look for specific movement patterns called “fidgety movements,” which are small, elegant motions healthy infants make. When these movements are absent, it’s a strong predictor of cerebral palsy, especially when paired with brain imaging.
For infants older than 5 months, the Hammersmith Infant Neurological Examination is the preferred tool. This is a scored clinical exam that evaluates things like posture, movement quality, reflexes, and tone. A total score below 73 at 6, 9, or 12 months signals high risk for cerebral palsy. Scores between 50 and 73 suggest a form that affects one side of the body, and these children will almost always walk independently. Scores below 50 suggest a form affecting both sides, often with greater motor limitations. Scores below 40 at 3 to 6 months point toward more severe movement difficulties.
Brain Imaging With MRI
An MRI of the brain is the most important imaging tool in a cerebral palsy evaluation. It reveals whether there is structural damage to areas of the brain that control movement, and it helps rule out other conditions. MRI shows abnormalities in more than 80% of children with cerebral palsy.
The most common finding is white matter injury, which accounts for roughly half of all cases. White matter contains the nerve fibers that carry signals between different brain regions, so damage here disrupts communication between the brain and the muscles. Gray matter injury, affecting the brain cells themselves, shows up in about 20% of cases. Brain malformations that occurred during fetal development account for around 11%. In about 10% of children with cerebral palsy, the MRI appears completely normal, which doesn’t rule out the diagnosis but does change how doctors think about the underlying cause.
The power of MRI increases when it’s combined with a clinical exam. For infants under 5 months, an abnormal MRI plus absent fidgety movements on the General Movements Assessment predicts cerebral palsy with over 95% accuracy. For older infants, an abnormal MRI plus a low score on the Hammersmith exam predicts it about 90% of the time.
Why Diagnosis Can Take Time
Even with these tools, diagnosis isn’t always fast. The brain continues developing throughout infancy, and mild forms of cerebral palsy may not become obvious until a child is expected to perform more complex motor tasks like walking or running. Children born prematurely present an additional challenge: their motor development is already expected to be slightly behind, so clinicians adjust for gestational age when interpreting milestones and exam scores.
A recent study from the American Academy of Pediatrics highlighted this tension. When MRI and standardized movement assessments were combined in preterm infants, the results were extremely reliable when positive (near 100% specificity for some combinations), meaning a positive result almost certainly meant cerebral palsy. But the sensitivity was low, meaning these tests missed a significant number of children who did go on to develop the condition. For moderate to severe cases, sensitivity was much better, ranging from 78% to 90%. The takeaway: a normal result on early testing doesn’t guarantee a child is unaffected, which is why ongoing developmental follow-up matters.
Ruling Out Other Conditions
Part of the diagnostic process involves making sure the symptoms aren’t caused by something else. Several conditions can look like cerebral palsy in early childhood, including inherited metabolic disorders, hereditary spastic paraplegias (genetic conditions that cause progressive leg stiffness), Rett syndrome, and tethered spinal cord. Some of these conditions are progressive, meaning they get worse over time, while cerebral palsy by definition results from a one-time brain injury that doesn’t worsen, even though symptoms may change as a child grows.
Genetic testing is playing a growing role in this process. Exome sequencing, which reads the protein-coding portions of a child’s DNA, identifies a genetic cause in anywhere from 6% to 55% of cases depending on the study population. This wide range reflects differences in which children are tested. Genetic results matter because they can uncover treatable conditions that mimic cerebral palsy, change the expected course of the condition, or inform family planning decisions.
Classifying Severity at Diagnosis
Once cerebral palsy is confirmed, doctors classify its severity using a system called the Gross Motor Function Classification System, which has five levels. This classification helps families understand what to expect in terms of mobility and independence.
- Level I: The child walks without restrictions but may have difficulty with advanced motor skills like running or jumping.
- Level II: The child walks in most settings but may struggle with uneven terrain, long distances, or crowded spaces.
- Level III: The child walks with a handheld assistive device indoors and uses wheeled mobility for longer distances.
- Level IV: The child uses powered mobility or is transported in a wheelchair in most settings, with some ability to stand for transfers.
- Level V: The child has very limited voluntary movement and requires full support for mobility, even with assistive technology.
This classification is based on what the child can currently do, not what they might do with therapy. It’s reassessed at different ages because motor abilities change as children grow, especially during the first several years.
The Diagnostic Team
Diagnosing cerebral palsy rarely falls to a single doctor. A pediatrician or family doctor typically raises the initial concern, and the child is then referred to one or more specialists. Pediatric neurologists evaluate brain and nervous system function. Developmental pediatricians focus on milestones and overall developmental trajectories. Physical medicine and rehabilitation specialists help assess movement and plan early intervention. Physical therapists, occupational therapists, and sometimes mental health specialists round out the team, particularly as the child moves from diagnosis into management.
For families in the middle of this process, the evaluation period can feel long and uncertain. Multiple appointments, imaging, and possibly genetic testing may stretch over weeks or months. The goal of current clinical guidelines is to shorten this window, because earlier identification means earlier access to therapies that can meaningfully influence a child’s motor development during the period when the brain is most adaptable.